Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review

被引：18

作者：

Prieto-Pena, Diana ^{[4
]}

Bernabeu, Pilar ^{[5
]}

Vela, Paloma ^{[5
]}

Narvaez, Javier ^{[6
]}

Fernandez-Lopez, Jesus C. ^{[7
]}

Freire-Gonzalez, Mercedes ^{[7
]}

Gonzalez-Alvarez, Beatriz ^{[8
]}

Solans-Laque, Roser ^{[9
]}

Callejas Rubio, Jose L. ^{[10
]}

Ortego, Norberto ^{[10
]}

Fernandez-Diaz, Carlos ^{[11
]}

Rubio, Esteban ^{[12
]}

Garcia-Morillo, Salvador ^{[12
]}

Minguez, Mauricio ^{[13
]}

Fernandez-Carballido, Cristina ^{[13
]}

de Miguel, Eugenio ^{[14
]}

Melchor, Sheila ^{[15
]}

Salgado, Eva ^{[16
]}

Bravo, Beatriz ^{[17
]}

Romero-Yuste, Susana ^{[18
]}

Salvatierra, Juan ^{[10
]}

Hidalgo, Cristina ^{[19
]}

Manrique, Sara ^{[20
]}

Romero-Gomez, Carlos ^{[20
]}

Moya, Patricia ^{[21
]}

Alvarez-Rivas, Noelia ^{[22
]}

Mendizabal, Javier ^{[23
]}

Ortiz-Sanjuan, Francisco ^{[24
]}

Perez de Pedro, Ivan ^{[25
]}

Alonso-Valdivielso, Jose L. ^{[26
]}

Perez-Sanchez, Laura ^{[27
]}

Roldan, Rosa ^{[27
]}

Fernandez-Llanio, Nagore ^{[28
]}

Gomez de la Torre, Ricardo ^{[29
]}

Suarez, Silvia ^{[29
]}

Montesa Cabrera, Maria Jesus ^{[8
]}

Delgado Sanchez, Monica ^{[8
]}

Loricera, Javier ^{[4
]}

Atienza-Mateo, Belen ^{[4
]}

Castaneda, Santos ^{[11
,30
]}

Gonzalez-Gay, Miguel A. ^{[1
,2
,3
]}

Blanco, Ricardo ^{[4
]}

机构：

[1] Hosp Univ Marques de Valdecilla, Rheumatol Div, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, IDIVAL, Ave Valdecilla S-N, Santander 39008, Spain

[2] Univ Cantabria, Sch Med, Santander, Spain

[3] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa

[4] Hosp Univ Marques de Valdecilla, Dept Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, Santander, Spain

[5] Hosp Gen Alicante, Dept Rheumatol, Alicante, Spain

[6] Hosp Bellvitge Princeps Espanya, Dept Rheumatol, Barcelona, Spain

[7] Complejo Hosp Univ A Coruna, Dept Rheumatol, La Coruna, Spain

[8] Hosp Nuestra Senora Candelaria, Dept Rheumatol, Tenerife, Spain

[9] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain

[10] Hosp San Cecilio, Autoimmune Dis Unit, Granada, Spain

[11] Hosp Univ Princesa, Dept Rheumatol, IIS Princesa, Madrid, Spain

[12] Hosp Virgen Rocio, Autoimmune Dis Unit, Seville, Spain

[13] Hosp San Juan Alicante, Dept Rheumatol, Alicante, Spain

[14] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain

[15] Hosp Univ 12 Octubre, Dept Rheumatol, Madrid, Spain

[16] Complejo Hosp Univ Ourense, Dept Rheumatol, Orense, Spain

[17] Hosp Virgen Nieves, Dept Rheumatol, Granada, Spain

[18] Complejo Hosp Univ Pontevedra, Dept Rheumatol, Pontevedra, Spain

[19] Complejo Univ Salamanca, Dept Rheumatol, Salamanca, Spain

[20] Hosp Reg Malaga, Autoimmune Dis Unit, Malaga, Spain

[21] Hosp Santa Creu & Sant Pau, Dept Rheumatol, Barcelona, Spain

[22] Hosp Univ San Agustin, Dept Rheumatol, Aviles, Spain

[23] Complejo Hosp Navarra, Dept Rheumatol, Pamplona, Spain

[24] Hosp Univ & Politecn La Fe, Dept Rheumatol, Valencia, Spain

[25] Hosp Carlos Haya, Autoimmune Dis Unit, Malaga, Spain

[26] Hosp Univ Burgos, Dept Rheumatol, Burgos, Spain

[27] Hosp Univ Reina Sofia, Dept Rheumatol, Cordoba, Spain

[28] Hosp Arnau Vilanova, Dept Rheumatol, Valencia, Spain

[29] Hosp Univ Cent Asturias, Autoimmune Dis Unit, Oviedo, Spain

[30] Univ Autonoma Madrid IUAMI, UAM ROCHE, EPID Future, Madrid, Spain

来源：

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE | 2021年 / 13卷

关键词：

biological therapy; Caucasian; cDMARDs; Takayasu's arteritis; Tocilizumab; DISEASE-ACTIVITY; EPIDEMIOLOGY; EFFICACY; FEATURES; CRITERIA; OUTCOMES; SAFETY; JAPAN;

D O I：

10.1177/1759720X211020917

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu's arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-sparing effect, improvement in imaging techniques, and adverse events. A comparative study between patients who received TCZ as monotherapy (TCZ(MONO)) and combined with conventional disease modifying anti-rheumatic drugs (cDMARDs) (TCZ(COMBO)) was performed. Results: The study comprised 54 patients (46 women/8 men) with a median [interquartile range (IQR)] age of 42.0 (32.5-50.5) years. TCZ was started after a median (IQR) of 12.0 (3.0-31.5) months since TAK diagnosis. Remission was achieved in 12/54 (22.2%), 19/49 (38.8%), 23/44 (52.3%), and 27/36 (75%) patients at 1, 3, 6, and 12 months, respectively. The prednisone dose was reduced from 30.0 mg/day (12.5-50.0) to 5.0 (0.0-5.6) mg/day at 12 months. An improvement in imaging findings was reported in 28 (73.7%) patients after a median (IQR) of 9.0 (6.0-14.0) months. Twenty-three (42.6%) patients were on TCZ(MONO) and 31 (57.4%) on TCZ(COMBO): MTX (n = 28), cyclosporine A (n = 2), azathioprine (n = 1). Patients on TCZ(COMBO) were younger [38.0 (27.0-46.0) versus 45.0 (38.0-57.0)] years; difference (diff) [95% confidence interval (CI) = -7.0 (-17.9, -0.56] with a trend to longer TAK duration [21.0 (6.0-38.0) versus 6.0 (1.0-23.0)] months; diff 95% CI = 15 (-8.9, 35.5), and higher c-reactive protein [2.4 (0.7-5.6) versus 1.3 (0.3-3.3)] mg/dl; diff 95% CI = 1.1 (-0.26, 2.99). Despite these differences, similar outcomes were observed in both groups (log rank p = 0.862). Relevant adverse events were reported in six (11.1%) patients, but only three developed severe events that required TCZ withdrawal. Conclusion: TCZ in monotherapy, or combined with cDMARDs, is effective and safe in patients with refractory TAK of Caucasian origin.

引用

页数：12

共 50 条

[21] Tocilizumab in refractory aortitis: a study on 16 patients and literature review
Loricera, J.
Blanco, R.
Castaneda, S.
Humbria, A.
Ortego-Centeno, N.
Narvaez, J.
Mata, C.
Melchor, S.
Aurrecoechea, E.
Calvo-Alen, J.
Lluch, P.
Moll, C.
Minguez, M.
Herrero-Beaumont, G.
Bravo, B.
Rubio, E.
Freire, M.
Peiro, E.
Gonzalez-Vela, C.
Rueda-Gotor, J.
Pina, T.
Palmou-Fontana, N.
Calvo-Rio, V.
Ortiz-Sanjuan, F.
Gonzalez-Gay, M. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S79 - S89
[22] Association of Takayasu's arteritis and Crohn's disease -: Results of a study on 44 Takayasu patients and review of the literature
Reny, JL
Paul, JF
Lefèbvre, C
Champion, K
Emmerich, J
Blétry, O
Piette, JC
Fiessinger, JN
ANNALES DE MEDECINE INTERNE, 2003, 154 (02): : 85 - 90
[23] Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis Two case reports
Asano, Tomoyuki
Sato, Shuzo
Temmoku, Jumpei
Fujita, Yuya
Furuya, Makiko Yashiro
Matsuoka, Naoki
Kobayashi, Hiroko
Suzuki, Eiji
Watanabe, Hiroshi
Migita, Kiyoshi
MEDICINE, 2020, 99 (04)
[24] Treatment of Refractory Takayasu Arteritis with Tocilizumab: 7 Italian Patients from a Single Referral Center
Tombetti, Enrico
Franchini, Stefano
Papa, Maurizio
Sabbadini, Maria Grazia
Baldissera, Elena
JOURNAL OF RHEUMATOLOGY, 2013, 40 (12) : 2047 - 2051
[25] Clinical presentation, treatment and outcome of Takayasu's arteritis in southern Chinese: a multicenter retrospective study
Wong, Stella Pui Yan
Mok, Chi Chiu
Lau, Chak Sing
Yip, Man Lung
Tam, Lai Shan
Ying, King Yee
Ng, Woon Leung
Ng, Kam Hung
Leung, Moon Ho
Lee, Tsz Yan
To, Chi Hung
Lee, Ka Lai
Wan, Man Choi
Yu, Ka Lung
Wong, Priscilla Ching Han
Sung, Chi Keung
Lee, Kwok Fai
Kun, Emily Wai Lin
RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) : 2263 - 2270
[26] Pediatric Takayasu Arteritis: A Review of the Literature
Haslak, Fatih
Yildiz, Mehmet
Sahin, Sezgin
Adrovic, Amra
Barut, Kenan
Kasapcopur, Ozgur
CURRENT PEDIATRIC REVIEWS, 2022, 18 (04) : 243 - 250
[27] Anti TNF-α in refractory Takayasu's arteritis: Cases series and review of the literature
Comarmond, Cloe
Plaisier, Emmanuel
Dahan, Karine
Mirault, Tristan
Emmerich, Joseph
Amoura, Zahir
Cacoub, Patrice
Saadoun, David
AUTOIMMUNITY REVIEWS, 2012, 11 (09) : 678 - 684
[28] Takayasu's Arteritis: A Special Case Report and Review of the Literature
Moisii, Paloma
Jari, Irina
Naum, Alexandru Gratian
Butcovan, Doina
Tinica, Grigore
MEDICINA-LITHUANIA, 2024, 60 (03):
[29] Pulmonary Arteries Involvement in Takayasu's Arteritis: Two Cases and Literature Review
Toledano, Kohava
Guralnik, Ludmila
Lorber, Avraham
Ofer, Amos
Yigla, Mordechai
Rozin, Alexander
Markovits, Doron
Braun-Moscovici, Yolanda
Balbir-Gurman, Alexandra
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (03) : 461 - 470
[30] Tocilizumab in treatment-naive patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial
Mekinian, Arsene
Saadoun, David
Vicaut, Eric
Thietart, Sara
Lioger, Bertrand
Jego, Patrick
Bleibtreu, Alexandre
Limal, Nicolas
Connault, Jerome
Gottenberg, Jacques-Eric
Lhorte, Pauline
Bertola, Jean Pierre
Delforge, Juliette
Ferreira-Maldent, Nicole
Perlat, Antoinette
Talib, Zohra
Vautier, Matthieu
Savey, Lea
Quiere, Isabelle
Cacoub, Patrice
Fain, Olivier
ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)

← 1 2 3 4 5 →